Pruritus means itching, a feeling that makes you want to scratch your skin. Sometimes it comes with a rash, but not always. If the itching lasts for six weeks or more, it’s called chronic pruritus.
In people with cancer, pruritus is more common, especially when taking certain modern cancer treatments known as targeted therapies or immunotherapies. These include:
- EGFR inhibitors (e.g. gefitinib, cetuximab, erlotinib, Osimertinib)
- Monoclonal antibodies (e.g. rituximab, tositumomab)
- Other targeted agents like VEGFR, BRAF, MEK, and mTOR inhibitors
- PD-1/PD-L1 inhibitors (e.g. nivolumab, pembrolizumab)
- CTLA-4 inhibitors (e.g. ipilimumab)
Studies showed that itching affects up to 1 in 7 cancer patients taking these treatments. Most of the cases are mild, but it can be more severe and affect daily life in some patients (about 1-2%).